scholarly journals A single weekly Kt/Vurea target for peritoneal dialysis patients does not provide an equal dialysis dose for all

2016 ◽  
Vol 90 (6) ◽  
pp. 1342-1347 ◽  
Author(s):  
Sally El-Kateb ◽  
Sivakumar Sridharan ◽  
Ken Farrington ◽  
Stanley Fan ◽  
Andrew Davenport
Keyword(s):  
Peritoneal Dialysis ◽  
Dialysis Patients ◽  
Dialysis Dose

Future Approaches to the Treatment of Malnutrition Malnutrition in Peritoneal Dialysis Patients: Etiologic Factors and Treatment Options

1995 ◽  
Vol 15 (5_suppl) ◽  
pp. 63-66 ◽  
Author(s):  
T. Alp Ikizler ◽  
Rebecca L. Wingard ◽  
Raymond M. Hakim
Keyword(s):  
Peritoneal Dialysis ◽  
Nutritional Status ◽  
Treatment Options ◽  
Nutritional Supplements ◽  
Chronic Dialysis ◽  
Dialysis Patients ◽  
Nutritional Counseling ◽  
Dialysis Dose ◽  
Early Start ◽  
Dialysis Solutions

It is clear that malnutrition is common in chronic dialysis patients and is associated with increased morbidity and mortality. Evidence is accumulating that several measures can be taken to improve the nutritional status of these patients. An early start of dialysis, an increase in dialysis dose, the use of biocompatible membranes or dialysis solutions, and intensive nutritional counseling should be applied when necessary. If these measures fail, additional interventions, such as parenteral or enteral nutritional supplements, rhGH, and rhIGF -1, alone or in combination, should be tried.

Trends in Anemia Management Practices in Patients Receiving Hemodialysis and Peritoneal Dialysis: A Retrospective Cohort Analysis

2015 ◽  
Vol 41 (4-5) ◽  
pp. 354-361 ◽  
Author(s):  
James B. Wetmore ◽  
Yi Peng ◽  
Keri L. Monda ◽  
Allyson M. Kats ◽  
Deborah H. Kim ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Management Practices ◽  
Cohort Analysis ◽  
Dialysis Patients ◽  
Dialysis Dose ◽  
Retrospective Cohort Analysis ◽  
Anemia Management ◽  
Iv Iron ◽  
The Mean ◽  
Rbc Transfusion

Background/Aims: Recent changes in clinical practice guidelines and reimbursement policies may have affected the use of anemia-related medications and red blood cell (RBC) transfusions in peritoneal dialysis (PD) and hemodialysis (HD) patients. We sought to compare patterns of erythropoiesis-stimulating agents (ESA) and intravenous (IV) iron use, achieved hemoglobin levels, and RBC transfusion use in PD and HD patients. Methods: In quarterly cohorts of prevalent dialysis patients receiving persistent therapy (>3 months), 2007-2011, with Medicare Parts A and B coverage, we assessed ESA and IV iron use and dose, RBC transfusions, and hemoglobin levels. Quarterly transfusion rates were calculated. Results: Observable PD and HD patients numbered 14,958 and 221,866 in Q1/2007 and 17,842 and 256,942 in Q4/2011. Adjusted ESA use was lower in PD (71.4-80.1%) than in HD (86.9-92.0%) patients, decreasing from 80.1% (Q1/2010) to 71.4% (Q4/2011) in PD patients, and from 92.0 to 86.9% in HD patients. The mean adjusted ESA dose decreased by 67.5% in PD and 58.4% in HD patients. IV iron use tended to increase, peaking at 39.3% for PD (Q3/2011) and 80.5% for HD (Q2/2011) patients. Adjusted mean hemoglobin levels fell from 11.7 to 10.6 mg/dl in PD and from 12.0 to 10.7 mg/dl in HD ESA users; adjusted transfusion rates increased from 2.4 to 3.0 per 100 patient-months in PD and from 2.6 to 3.3 in HD patients. Conclusions: In patients receiving persistent dialysis, dose and frequency of ESA administrations decreased during the period 2007-2011. Mean hemoglobin levels decreased by more than 1 g/dl, while transfusion rates increased by approximately 25%.

Assessment of Dialysis Dose by Measured Clearance versus Extrapolated Data

1993 ◽  
Vol 13 (3) ◽  
pp. 184-188 ◽  
Author(s):  
John M. Burkart ◽  
Jean R. Jordan ◽  
Michael V. Rocco
Keyword(s):  
Peritoneal Dialysis ◽  
University Teaching ◽  
Peritoneal Membrane ◽  
Dialysis Patients ◽  
Peritoneal Equilibration Test ◽  
Dialysis Dose ◽  
Dialysis Unit ◽  
Daily Dialysis ◽  
The Individual ◽  
Chronic Ambulatory Peritoneal Dialysis

Objective To determine whether estimates of daily dialysis clearance of creatinine and urea, based on data from the 4-hour peritoneal equilibration test, correlate well with daily dialysis clearance measured by 24-hour dialysate collection in chronic ambulatory peritoneal dialysis patients. Design Prospective study in which each subject collected all dialysate from a 24-hour period and then immediately thereafter underwent a standard peritoneal equilibration test (PET). Daily clearances of creatinine and urea were calculated from 24-hour dialysate collections by standard methods and then were compared with several estimates of 24-hour clearance based on PET data. Setting Single peritoneal dialysis unit of a university teaching hospital. Patients Thirty-six stable patients on continuous ambulatory peritoneal dialysis (CAPD). Main Outcome The estimated values for daily dialysis clearance both overestimated and underestimated the measured 24-hour clearance. The correlation coefficient between the extrapolations and the actual 24-hour clearances ranged from 0.63–0.68. The range of discordance for daily creatinine clearance was from -2530 mL/dayto +2199 mL/day. For daily urea clearance, the range of discordance was from -21 03 mL/ day to +1940 mL/day. The peritoneal membrane transport characteristics of the individual patient did not predict whether the extrapolation overestimated orunder estimated the measured daily clearance. Conclusion Extrapolation of PET data is not a reliable method to estimate the dose of dialysis delivered to the patient. A 24-hour collection of dialysis is necessary for this determination.

Which Method Should Be Used to Assess Protein Intake in Peritoneal Dialysis Patients? Assessment of Agreement Between Protein Equivalent of Total Nitrogen Appearance and 24-Hour Dietary Recall

2020 ◽  
Author(s):  
Maryanne Zilli Canedo Silva ◽  
Barbara Perez Vogt ◽  
Nayrana Soares Carmo Reis ◽  
Rogerio Carvalho Oliveira ◽  
Jacqueline Costa Teixeira Caramori
Keyword(s):  
Peritoneal Dialysis ◽  
Total Nitrogen ◽  
Protein Intake ◽  
Dialysis Patients ◽  
Dietary Recall

Prevalence of abnormalities in electrocardiogram conduction in dialysis patients: a comparative study

2020 ◽  
Author(s):  
Firas Ajam ◽  
Arda Akoluk ◽  
Anas Alrefaee ◽  
Natasha Campbell ◽  
Avais Masud ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Cardiac Conduction ◽  
Future Research ◽  
Dialysis Patients ◽  
Bundle Branch Block ◽  
Conduction Abnormality ◽  
Ckd Stage ◽  
Stage 1 ◽  
Electrocardiogram Ecg ◽  
Ecg Abnormalities

ABSTRACT Background: The electrocardiogram (ECG) can aid in identification of chronic kidney disease (CKD) patients at high risk for cardiovascular diseases. Cohort studies describe ECG abnormalities in patients on hemodialysis (HD), but we did not find data comparing ECG abnormalities among patients with normal kidney function or peritoneal dialysis (PD) to those on hemodialysis. We hypothesized that ECG conduction abnormalities would be more common, and cardiac conduction interval times longer, among patients on hemodialysis vs. those on peritoneal dialysis and CKD 1 or 2. Methods: Retrospective review of adult inpatients’ charts, comparing those with billing codes for “Hemodialysis” vs. inpatients without those charges, and an outpatient peritoneal dialysis cohort. Patients with CKD 3 or 4 were excluded. Results: One hundred and sixty-seven charts were reviewed. ECG conduction intervals were consistently and statistically longer among hemodialysis patients (n=88) vs. peritoneal dialysis (n=22) and CKD stage 1 and 2 (n=57): PR (175±35 vs 160±44 vs 157±22 msec) (p=0.009), QRS (115±32 vs. 111±31 vs 91±18 msec) (p=0.001), QT (411±71 vs. 403±46 vs 374±55 msec) (p=0.006), QTc (487±49 vs. 464±38 vs 452±52 msec) (p=0.0001). The only significantly different conduction abnormality was prevalence of left bundle branch block: 13.6% among HD patients, 5% in PD, and 2% in CKD 1 and 2 (p=0.03). Conclusion: To our knowledge, this is the first study to report that ECG conduction intervals are significantly longer as one progresses from CKD Stage 1 and 2, to PD, to HD. These and other data support the need for future research to utilize ECG conduction times to identify dialysis patients who could potentially benefit from proactive cardiac evaluations and risk reduction.

Impact of quality of life on the compliance in hemodialysis and peritoneal dialysis patients in Qassim, Saudi Arabia

2021 ◽  
pp. 146-151
Author(s):  
Albatool Almousa ◽  
Fai Almarshud ◽  
Razan Almasuood ◽  
Marya Alyahya ◽  
Chandra Kalevaru ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Saudi Arabia ◽  
Peritoneal Dialysis ◽  
Dialysis Patients
Sign in / Sign up

Export Citation Format

Share Document